Prelude Capital Management’s Community Health Systems, Inc. Series A Contingent Value Rights CYHHZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-33,000
Closed 2412
2018
Q4
$0 Hold
33,000
﹤0.01% 2377
2018
Q3
$0 Hold
33,000
﹤0.01% 2210
2018
Q2
$0 Hold
33,000
﹤0.01% 2103
2018
Q1
$0 Hold
33,000
﹤0.01% 1856
2017
Q4
$0 Buy
33,000
+351
+1% +$3 ﹤0.01% 1912
2017
Q3
$0 Sell
32,649
-5,000
-13% -$72 ﹤0.01% 2048
2017
Q2
$1K Hold
37,649
﹤0.01% 1563
2017
Q1
$0 Hold
37,649
﹤0.01% 1928
2016
Q4
$0 Hold
37,649
﹤0.01% 1921
2016
Q3
$0 Hold
37,649
﹤0.01% 1952
2016
Q2
$0 Hold
37,649
﹤0.01% 1844
2016
Q1
$0 Hold
37,649
﹤0.01% 1678
2015
Q4
$0 Hold
37,649
﹤0.01% 1817
2015
Q3
$0 Hold
37,649
﹤0.01% 1944
2015
Q2
$1K Buy
+37,649
New +$708 ﹤0.01% 1646

Other funds holding CYHHZ

Prelude Capital Management's CYHHZ Position: Q1 2019 in Review

Prelude Capital Management sold out of Community Health Systems, Inc. Series A Contingent Value Rights (CYHHZ) in Q1 2019, closing a stake of 33,000 shares.

Prelude Capital Management first reported a position in CYHHZ in Q2 2015 and held it in 15 quarters. The position peaked at $1K in Q2 2017. 1 fund tracked by Wall St. Rank holds CYHHZ as of Q1 2019.

  • Prelude Capital Management reported no remaining Community Health Systems, Inc. Series A Contingent Value Rights position as of Q1 2019 after selling out during the quarter.
  • Prelude Capital Management sold 33,000 Community Health Systems, Inc. Series A Contingent Value Rights shares in Q1 2019.
  • Prelude Capital Management first reported a position in Community Health Systems, Inc. Series A Contingent Value Rights in Q2 2015 and held it in 15 quarters.
  • Prelude Capital Management's Community Health Systems, Inc. Series A Contingent Value Rights position peaked at $1K in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Community Health Systems, Inc. Series A Contingent Value Rights as of Q1 2019.

Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.